Evidence map›Paper›PMID 31642515›Full record

ArticleImmunology2020

Annexin V expression on CD4

Anna-Lena Bollinger, Thomas Bollinger, Jan Rupp, Kensuke Shima, Natalie Gross, Laura Padayachy, Rachel Chicheportiche, Gisella L Puga Yung, Jörg Dieter Seebach

Abstract read
In one paragraph

Article in Immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Annexin A5 suppression promotes the progression of cervical cancer.Archives of gynecology and obstetrics · 2023
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Anna-Lena BollingerDivision of Immunology and Allergology, Department of Medicine, University Hospitals and Medical Faculty, Geneva, Switzerland.ORCID 0000-0003-0100-1227
Thomas BollingerDepartment of Molecular Biology, University of Geneva, Geneva, Switzerland.ORCID 0000-0003-2842-9610
Jan RuppDepartment of Infectious Diseases and Microbiology, University of Lübeck, Lübeck, Germany.ORCID 0000-0001-8722-1233
Kensuke ShimaDepartment of Infectious Diseases and Microbiology, University of Lübeck, Lübeck, Germany.ORCID 0000-0002-5357-4230
Natalie GrossLübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.ORCID 0000-0003-0773-3285
Laura PadayachyDivision of Immunology and Allergology, Department of Medicine, University Hospitals and Medical Faculty, Geneva, Switzerland.
Rachel ChicheporticheDivision of Immunology and Allergology, Department of Medicine, University Hospitals and Medical Faculty, Geneva, Switzerland.
Gisella L Puga YungDivision of Immunology and Allergology, Department of Medicine, University Hospitals and Medical Faculty, Geneva, Switzerland.ORCID 0000-0002-2283-7798
Jörg Dieter SeebachDivision of Immunology and Allergology, Department of Medicine, University Hospitals and Medical Faculty, Geneva, Switzerland.ORCID 0000-0001-5748-4577

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regulatory T (Treg) cells induce immunologic tolerance by suppressing effector functions of conventional lymphocytes in the periphery. On the other hand, immune silencing is mediated by recognition of phosphatidylserine (PS) on apoptotic cells by phagocytes. Here we describe expression of the PS-binding protein Annexin V (ANXA5) in CD4

Indexed as

Lymphocyte ActivationAnimalsAnnexin A5Cell AdhesionCell ProliferationCells, CulturedCytokinesDisease Models, AnimalEndothelial CellsHumansHypersensitivity, DelayedMaleMice, Inbred C57BLPhenotypePhosphatidylserinesPhosphorylationAnnexin A5ANXA5 protein, humanAnxa5 protein, mouseCytokinesMTOR protein, humanPhosphatidylserinesTOR Serine-Threonine KinasesregulationsuppressionT cells

Identifiers

PMID31642515
PMCPMC6954731

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.